Health Industry Watch
SEE OTHER BRANDS

Your healthcare and wellness news reporter

Health Industry Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.

Press releases published on March 2, 2025

AION Healthspan Launches First-in-Human Clinical Trial for REJUVXL™ Cell Therapy in Chronic Kidney Disease

AION Healthspan Launches First-in-Human Clinical Trial for REJUVXL™ Cell Therapy in Chronic Kidney Disease

AION Healthspan announces enrollment for its first-in-human Phase I/II clinical trial in Diabetic Nephropathy and other forms of Chronic Kidney Disease. MIAMI, FL, UNITED STATES, March 2, 2025 /⁨EINPresswire.com⁩/ -- AION Healthspan, Inc., a clinical- …

Dr. Austin Khorasanchi Joins Babylon Dental Care, Bringing Expertise and Passion for Patient-Centered Dentistry

Dr. Austin Khorasanchi Joins Babylon Dental Care, Bringing Expertise and Passion for Patient-Centered Dentistry

BABYLON, NY, UNITED STATES, March 2, 2025 /⁨EINPresswire.com⁩/ -- Babylon Dental Care is excited to welcome Dr. Austin Khorasanchi to its team of skilled dental professionals. Dr. Khorasanchi officially joins the practice on February 17, 2025, bringing a …

Dr. Linda Nguyen Joins Babylon Dental Care, Expanding Exceptional Patient Care

Dr. Linda Nguyen Joins Babylon Dental Care, Expanding Exceptional Patient Care

BABYLON, NY, UNITED STATES, March 2, 2025 /⁨EINPresswire.com⁩/ -- Babylon Dental Care proudly welcomes Dr. Linda Nguyen to its team of dedicated dental professionals. Dr. Nguyen officially joined the practice on January 7, 2025, bringing a wealth of …

Healthcare Waste Treatment Market to Reach $31.4 Billion, Globally, by 2035 at 5.5% CAGR: Allied Market Research

Healthcare Waste Treatment Market to Reach $31.4 Billion, Globally, by 2035 at 5.5% CAGR: Allied Market Research

Wilmington, Delaware, March 02, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Healthcare Waste Treatment Market by Treatment (Incineration, Autoclaving, Chemical Treatment, and Others), Type of Waste (Hazardous waste and Non- …

Lexicon Pharmaceuticals to Announce Topline Results from Phase 2b PROGRESS Study Evaluating Pilavapadin (LX9211) in Adults with Diabetic Peripheral Neuropathic Pain

Lexicon Pharmaceuticals to Announce Topline Results from Phase 2b PROGRESS Study Evaluating Pilavapadin (LX9211) in Adults with Diabetic Peripheral Neuropathic Pain

THE WOODLANDS, Texas, March 02, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will hold a conference call and webcast on Monday, March 3, 2025 at 8:00 a.m. ET to share topline results from the Phase 2b …

Merus gibt Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 bekannt und berichtet über die Geschäftsentwicklung

Merus gibt Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 bekannt und berichtet über die Geschäftsentwicklung

- Phase-III-Zulassungsstudien zu Petosemtamab in Kombination mit Pembrolizumab in der Erstlinienbehandlung des PD-L1-positiven rezidivierten/metastasierten Kopf-Hals-Plattenepithelkarzinoms (r/m HNSCC) und Petosemtamab als Monotherapie in der Zweit-/ …

Merus annonce les résultats financiers de son quatrième trimestre et de l’ensemble de son exercice 2024, et fait le point sur ses activités

Merus annonce les résultats financiers de son quatrième trimestre et de l’ensemble de son exercice 2024, et fait le point sur ses activités

- Inclusion en cours pour les études d’enregistrement de phase III visant l’évaluation du pétosemtamab en association avec le pembrolizumab en traitement de 1ᵉ ligne pour un CETC r/m PD-L1 et l’évaluation du pétosemtamab en monothérapie de 2ᵉ et 3ᵉ ligne …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service